首页> 美国卫生研究院文献>Scientific Reports >Human erythrocytes release ATP by a novel pathway involving VDAC oligomerization independent of pannexin-1
【2h】

Human erythrocytes release ATP by a novel pathway involving VDAC oligomerization independent of pannexin-1

机译:人红细胞通过涉及VDAC寡聚的新途径释放ATP而该新途径独立于pannexin-1

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We previously demonstrated that the translocase protein TSPO2 together with the voltage-dependent anion channel (VDAC) and adenine nucleotide transporter (ANT) were involved in a membrane transport complex in human red blood cells (RBCs). Because VDAC was proposed as a channel mediating ATP release in RBCs, we used TSPO ligands together with VDAC and ANT inhibitors to test this hypothesis. ATP release was activated by TSPO ligands, and blocked by inhibitors of VDAC and ANT, while it was insensitive to pannexin-1 blockers. TSPO ligand increased extracellular ATP (ATPe) concentration by 24–59% over the basal values, displaying an acute increase in [ATPe] to a maximal value, which remained constant thereafter. ATPe kinetics were compatible with VDAC mediating a fast but transient ATP efflux. ATP release was strongly inhibited by PKC and PKA inhibitors as well as by depleting intracellular cAMP or extracellular Ca2+, suggesting a mechanism involving protein kinases. TSPO ligands favoured VDAC polymerization yielding significantly higher densities of oligomeric bands than in unstimulated cells. Polymerization was partially inhibited by decreasing Ca2+ and cAMP contents. The present results show that TSPO ligands induce polymerization of VDAC, coupled to activation of ATP release by a supramolecular complex involving VDAC, TSPO2 and ANT.
机译:我们以前证明,转位酶蛋白TSPO2与电压依赖性阴离子通道(VDAC)和腺嘌呤核苷酸转运蛋白(ANT)一起参与人红细胞(RBC)的膜转运复合物。由于VDAC被认为是介导RBC中ATP释放的通道,因此我们使用TSPO配体以及VDAC和ANT抑制剂来检验这一假设。 ATP的释放被TSPO配体激活,并被VDAC和ANT的抑制剂阻断,而对pannexin-1阻断剂不敏感。 TSPO配体使细胞外ATP(ATPe)浓度比基础值增加了24–59%,显示[ATPe]急剧增加至最大值,此后保持不变。 ATPe动力学与介导快速但短暂的ATP外流的VDAC相容。 ATP的释放受到PKC和PKA抑制剂以及细胞内cAMP或细胞外Ca 2 + 的强烈抑制,这提示了涉及蛋白激酶的机制。 TSPO配体有利于VDAC聚合,比未刺激的细胞产生更高的寡聚带密度。降低Ca 2 + 和cAMP含量可部分抑制聚合反应。目前的结果表明,TSPO配体诱导VDAC聚合,并通过涉及VDAC,TSPO2和ANT的超分子复合物激活ATP释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号